Seoul, South Korea

Seung Ki Kwok

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Seung Ki Kwok: Innovator in Rheumatoid Arthritis Treatment

Introduction

Seung Ki Kwok is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of rheumatoid arthritis. With a total of 3 patents, his work focuses on innovative pharmaceutical compositions that utilize mesenchymal stem cells.

Latest Patents

Kwok's latest patents include a pharmaceutical composition for preventing or treating rheumatoid arthritis, which comprises nasal inferior turbinate-derived mesenchymal stem cells as an active ingredient. This invention highlights the potential of these stem cells to reduce inflammation-inducing factors and enhance immune tolerance. Additionally, he has developed a RAPO strain, which is aimed at alleviating, treating, or preventing rheumatoid arthritis, showcasing his commitment to advancing therapeutic options in this area.

Career Highlights

Throughout his career, Seung Ki Kwok has been associated with notable institutions such as the Catholic University Industry Academic Cooperation Foundation and The Catholic University of Korea. His work has not only contributed to academic knowledge but has also paved the way for practical applications in medical treatments.

Collaborations

Kwok has collaborated with esteemed colleagues, including Sung Won Kim and Jaeseon Lee, to further his research and development efforts. These partnerships have been instrumental in enhancing the impact of his inventions.

Conclusion

Seung Ki Kwok stands out as an innovative inventor dedicated to improving treatments for rheumatoid arthritis through his groundbreaking research and patents. His contributions are poised to make a significant difference in the lives of those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…